KDM6A and hepatocellular carcinoma: Moreover, to validate this result, the colony formation assays were conducted and revealed that KDM6A knockdown reduced the sensitivity of HCC cells to lenvatinib treatment in human MHCC‐97H and mouse Hepa1–6 cell lines (Figure 7C,D).